Stock MAAT MAAT PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Revisions MaaT Pharma

Equities

MAAT

FR0012634822

Real-time Euronext Paris
Other stock markets
 03:02:34 2024-04-29 EDT 		5-day change 1st Jan Change
9.3 EUR +2.65% Intraday chart for MaaT Pharma +5.44% +33.24%
04-15 MaaT Pharma: positive data in graft-versus-host disease CF
04-15 MaaT Pharma Presents Positive 18-Month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. MAAT Stock
  4. Revisions MaaT Pharma